Art

J-GLOBAL ID：201702231460539364   Reference number：17A0139531

Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer

エストロゲン受容体陽性,HER2陰性乳癌における初期および後期の遠隔部位再発を予測する臨床病理因子

Author (18)： Yamashita Hiroko (Breast Surgery, Hokkaido University Hospital, Sapporo, Japan) ,  Ogiya Akiko (Breast Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Shien Tadahiko (Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan) ,  Horimoto Yoshiya (Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan) ,  Masuda Norikazu (Department of Surgery, Breast oncology, NHO Osaka National Hospital, Osaka, Japan) ,  Inao Touko (Department of Breast and Endocrine Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan) ,  Osako Tomofumi (Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto, Japan) ,  Osako Tomofumi (Kumamoto Shinto General Hospital, Kumamoto, Japan) ,  Takahashi Masato (Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan) ,  Endo Yumi (Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan) ,  Hosoda Mitsuchika (Breast Surgery, Hokkaido University Hospital, Sapporo, Japan) ,  Ishida Naoko (Breast Surgery, Hokkaido University Hospital, Sapporo, Japan) ,  Horii Rie (Division of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Yamazaki Kieko (Breast Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Miyoshi Yuichiro (Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan) ,  Yasojima Hiroyuki (Department of Surgery, Breast oncology, NHO Osaka National Hospital, Osaka, Japan) ,  Tomioka Nobumoto (Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan) ,  Collaborative Study Group of Scientific Research of the Japanese Breas
Material： Breast Cancer
Volume： 23  Issue： 6  Page： 830-843  Publication year： Nov. 2016 
JST Material Number： L3971A  ISSN： 1340-6868  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *breast tumor ,...
Semi thesaurus term： *estrogen receptor positive breast cancer ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0139531&from=J-GLOBAL&jstjournalNo=L3971A") }}

Author keywords (5)： Breast cancer ,  Late recurrence ,  Early recurrence ,  Estrogen receptor positive ,  HER2 negative

JST classification (2)： Diagnosis of tumors(=neoplasms)  (GE03020J) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Tamoxifen

Reference (25)：

• Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386:1341-52.
• Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378:771-84.
• Palmieri C, Jones A. The 2011 EBCTCG polychemotherapy overview. Lancet. 2012;379:390-2.
• Jatoi I, Anderson WF, Jeong JH, Redmond CK. Breast cancer adjuvant therapy: time to consider its time-dependent effects. J Clin Oncol. 2011;29:2301-4.
• Goss PE, Ingle JN, Pater JL, Martino S, Robert NJ, Muss HB, et al. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol. 2008;26:1948-55.

Terms in the title (7)： エストロゲン受容体 ,  HER2陰性乳癌 ,  初期 ,  再発 ,  予測 ,  臨床病理 ,  因子